In Silico Identification of Rosmarinic Acid as a Putative Natural Product Binder of the PI3Kα Allosteric Site
PIK3CA mutations drive tumorigenesis by activating phosphatidylinositol 3-kinase alpha (PI3Kα). The allosteric inhibitor STX-478 exhibits high selectivity toward PI3Kα and avoids adverse effects such as hyperglycemia. Hyperglycemia is the main reason for the limited clinical application of ATP-competitive PI3Kα inhibit...